![Mats Johan Peter Thorén](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats Johan Peter Thorén
Directeur/Membre du Conseil chez
C-RAD AB
Fortune : 77 253 $ au 30/06/2026
Profil
Mr. Mats Johan Peter Thorén is an Independent Director at C-RAD AB, an Independent Director at Bioporto A/S, an Independent Director at Herantis Pharma Oyj, an Independent Director at Xbrane Biopharma AB, an Independent Director at Arcoma AB, a Chief Executive Officer & Director at Vixco Capital AB and a Deputy Director at Eggelbertus Holding AB. He is on the Board of Directors at C-RAD AB, Bioporto A/S, FluoGuide A/S, Herantis Pharma Oyj, Xbrane Biopharma AB, Arcoma AB, Vixco Capital AB, Arcoma Incentive AB and Pulsetten AB. Mr. Thorén was previously employed as an Investment Manager by MedCap AB, a Founding Partner by Catella Healthcare AB, an Analyst by Enskilda Securities AB, an Analyst by Skandinaviska Enskilda Banken AB (Broker), and a Principal by Svenska Handelsbanken AB (Broker).
He also served on the board at Attana AB, DuoCort AB, IMIX Holding AB, Inter Life Science AB, Millicore AB, MIP Technologies AB, Nalka Life Science AB and Takara Bio Europe AB. He received his undergraduate degree from Karolinska Institutet and an undergraduate degree from Stockholm School of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOPORTO A/S 0,09% | 31/12/2025 | 448 195 ( 0,09% ) | 74 037 $ | 30/06/2026 |
| 31/12/2024 | 741 ( 0% ) | 3 216 $ | 30/06/2026 |
Postes actifs de Mats Johan Peter Thorén
| Sociétés | Poste | Début |
|---|---|---|
| ARCOMA AB | Directeur/Membre du Conseil | 01/01/2012 |
| HERANTIS PHARMA OYJ | Directeur/Membre du Conseil | 11/03/2020 |
| FLUOGUIDE A/S | Directeur/Membre du Conseil | 01/01/2021 |
| XBRANE BIOPHARMA AB | Directeur/Membre du Conseil | 01/01/2020 |
| BIOPORTO A/S | Directeur/Membre du Conseil | 30/04/2024 |
| C-RAD AB | Directeur/Membre du Conseil | 15/05/2024 |
Eggelbertus Holding AB | Corporate Officer/Principal | - |
Arcoma Incentive AB | Directeur/Membre du Conseil | - |
Pulsetten AB | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Mats Johan Peter Thorén
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Mats Johan Peter Thorén
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
C-RAD AB
 C-RAD AB Medical SpecialtiesHealth Technology Engages in the management and marketing of its subsidiaries products and solutions for radiation therapy | Health Technology |
Enskilda Securities AB
 Enskilda Securities AB Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcoma AB
 Arcoma AB Medical SpecialtiesHealth Technology Delivers digital radiographic systems | Health Technology |
Svenska Handelsbanken AB (Broker)
 Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millicore AB
 Millicore AB Electronic Equipment/InstrumentsElectronic Technology Develops and markets digital disposable products for the healthcare industry | Electronic Technology |
Attana AB
 Attana AB Medical/Nursing ServicesHealth Services Develops biosensors for the pharmaceutical, diagnostic, and academic societies | Health Services |
Skandinaviska Enskilda Banken AB (Broker)
 Skandinaviska Enskilda Banken AB (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Catella Healthcare AB
 Catella Healthcare AB Investment ManagersFinance Alternative investment manager | Finance |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
MIP Technologies AB
 MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services Develops molecularly imprinted polymers | Commercial Services |
Inter Life Science AB
 Inter Life Science AB Financial ConglomeratesFinance Provides investment services | Finance |
IMIX Holding AB
 IMIX Holding AB MiscellaneousMiscellaneous Holding company | Miscellaneous |
DuoCort AB
 DuoCort AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Xbrane Biopharma AB
 Xbrane Biopharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilars for s eye diseases | Health Technology |
Vixco Capital AB
 Vixco Capital AB Insurance Brokers/ServicesFinance Provides financial and insurance services | Finance |
Herantis Pharma Oyj
 Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
Pulsetten AB | |
FluoGuide A/S
 FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
Arcoma Incentive AB | |
Eggelbertus Holding AB |
Choisissez Zonebourse 
